Participation in the ASAGI Labs Longevity Consortium for Research and Social Implementation in the Longevity Field
Alfresa Holdings has announced its participation in the ASAGI Labs Longevity Consortium, established by ASAGI Labs. Aiming to extend healthy life expectancy and promote sustainable social participation in the 100-year life era, the company will leverage its healthcare expertise to drive innovation through industry-academia-government-finance collaboration. Full-scale activities begin on June 1, 2026.
📋 Article Processing Timeline
- 📰 Published: June 1, 2026 at 15:00
- 🔍 Collected: June 1, 2026 at 15:27 (27 min after Published)
- 🤖 AI Analyzed: June 1, 2026 at 18:04 (2h 37m after Collected)
We are pleased to announce that our company has joined the "ASAGI Labs Longevity Consortium," established by ASAGI Labs (Representative Director: Motoshi Hayano), with the objective of co-creating research, development, and new businesses related to longevity (extending healthy life expectancy and sustainable social participation).
With the arrival of the 100-year life era, creating a society where everyone, from the elderly to the young, has a place to thrive and can live with peace of mind has become a critical challenge. Against this backdrop, the concept of "longevity" is gaining traction, aiming not just for long life or curing diseases, but for a state where individuals can remain engaged with society while maintaining health at every stage of life. While the longevity field presents complex challenges that cannot be solved by academia, companies, or local governments alone, the results of basic research in this area can be applied to diverse industries, including food, pharmaceuticals, financial products, travel, hospitality, and even the space industry.
Under the group philosophy of "creating and delivering a vibrant life for all," the Alfresa Group has set "extending healthy life expectancy," "contributing to regional medical care," and "healthcare innovation" as the three themes for social value creation in its "Alfresa Group Medium- to Long-Term Vision" through fiscal year 2032.
The "ASAGI Labs Longevity Consortium" was established on April 1, 2026, as a co-creation platform where academia, companies, local governments, medical institutions, and non-profit organizations collaborate to drive innovation in various fields related to daily life, such as medicine, food, housing, and beauty. The consortium will begin full-scale activities on June 1, 2026, with the aim of co-creating research and new businesses, and is expected to generate new value that transcends industrial boundaries.
Aiming to contribute to "extending healthy life expectancy," we have agreed with the purpose of this consortium and decided to participate. By leveraging the knowledge we have cultivated in the medical and healthcare fields, we will contribute to solving social issues such as extending healthy life expectancy and sustainable social participation through industry-academia-government-finance collaboration.
With the arrival of the 100-year life era, creating a society where everyone, from the elderly to the young, has a place to thrive and can live with peace of mind has become a critical challenge. Against this backdrop, the concept of "longevity" is gaining traction, aiming not just for long life or curing diseases, but for a state where individuals can remain engaged with society while maintaining health at every stage of life. While the longevity field presents complex challenges that cannot be solved by academia, companies, or local governments alone, the results of basic research in this area can be applied to diverse industries, including food, pharmaceuticals, financial products, travel, hospitality, and even the space industry.
Under the group philosophy of "creating and delivering a vibrant life for all," the Alfresa Group has set "extending healthy life expectancy," "contributing to regional medical care," and "healthcare innovation" as the three themes for social value creation in its "Alfresa Group Medium- to Long-Term Vision" through fiscal year 2032.
The "ASAGI Labs Longevity Consortium" was established on April 1, 2026, as a co-creation platform where academia, companies, local governments, medical institutions, and non-profit organizations collaborate to drive innovation in various fields related to daily life, such as medicine, food, housing, and beauty. The consortium will begin full-scale activities on June 1, 2026, with the aim of co-creating research and new businesses, and is expected to generate new value that transcends industrial boundaries.
Aiming to contribute to "extending healthy life expectancy," we have agreed with the purpose of this consortium and decided to participate. By leveraging the knowledge we have cultivated in the medical and healthcare fields, we will contribute to solving social issues such as extending healthy life expectancy and sustainable social participation through industry-academia-government-finance collaboration.
FAQ
What can Taiwanese companies learn from this consortium?
They can gain insights into frameworks for social implementation through industry-academia-government-finance collaboration and knowledge on developing new businesses focused on healthy longevity.